The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, Kihealth raised $5 million in seed funding to launch its early detection test.
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout